3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
2
Fallopian Tube Neoplasms
2
Uterine Cervical Dysplasia
1
Thromboembolism
1
Precancerous Conditions
1
Postoperative Hemorrhage
1
Platinum Resistant Ovarian Cancer
1
Peripheral Nervous System Diseases
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Blood Loss, Surgical
1
Interventions
Cisplatin
7
Radiotherapy
3
Paclitaxel
3
Carboplatin
3
Brachytherapy
2
zimberelimab
1
piperine
1
pembrolizumab
1
durvalumab
1
camrelizumab
1
atezolizumab
1
Sodium Chloride
1
Neoadjuvant Therapy
1
Gemcitabine
1
Drug Therapy
1
Curcumin
1
Chemoradiotherapy
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Cervical Cancer
×
Sodium Chloride
×
Gynecologic
×
Clear all
NCT06079671
2026-05-27
eVOLVECervical
AstraZeneca
Phase 3
Recruiting
800 enrolled